Search
for
Sort by
Research 30 of 145
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- Radiation-induced alopecia
- LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers
- Invasive cutaneous squamous cell carcinoma of scalp: A case report
- Actinic Keratosis: Risk Factors, Clinical, Diagnosis and Therapeutics Aspects. Part I
- PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- MmuPV1-Induced Cutaneous Squamous Cell Carcinoma Arises Preferentially from Lgr5+ Epithelial Progenitor Cells
- Germline Mutation in ATR in Autosomal- Dominant Oropharyngeal Cancer Syndrome
- PRF Lysates Modulate Chemokine Expression in Oral Squamous Carcinoma and Healthy Epithelial Cells
- Elevated <em>DKK1</em> expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
- Beta Human Papillomavirus and Merkel Cell Polyomavirus in Skin Neoplasms
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- American Society for Laser Medicine and Surgery - 2018 Late-Breaking Abstracts
- The human keratins: biology and pathology
- Role of the Wnt signaling pathway in keratoacanthoma
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Management of congenital ichthyoses: European guidelines of care, part two
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Parkinson's disease and skin
- Distinct Conditions Support a Novel Classification for Bradykinin-Mediated Angio-Oedema
- Biological effects of human placental extracts - variations in manufacturing methods and compositions
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Geriatric Dermatologic Therapy
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program